Tyrosine-kinase inhibitor

Mar 21, 2019

Kanazawa University Research: Origin of Resistance to Lung-cancer Drug Discovered

Feb 05, 2019

Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor

Jan 11, 2019

Global Tyrosine Kinase Inhibitors Market 2019-2023 - Recent Approvals of TKIs, Side Effects of TKIs & Competitive Landscape

Jan 07, 2019

The tyrosine kinase inhibitors market will register a CAGR of more than 8% by 2023

Dec 03, 2018

Ascentage Pharma Announces Oral Presentation of Novel, Third-Generation BCR-ABL Inhibitor in Myelogenous Leukemia Patients at the 60th American Society of Hematology Annual Meeting

Nov 15, 2018

Tolero Pharmaceuticals Presents Clinical Data of AXL Kinase Inhibitor TP-0903 Showing its Ability to Enhance Host Immune Responses to Tumors

Sep 04, 2018

Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna®(nilotinib)

Nov 28, 2017

Chronic Myelogenous Leukemia Treatment Market Value to Reach US$ 8,550.8 Million by the end of 2026: Transparency Market Research